Inactivated influenza vaccine effectiveness against influenza-like illness among young children in Japan-With special reference to minimizing outcome misclassification

Vaccine

Volumn 27, Issue 50, 2009, Pages 7031-7035

  Ochiai, Hirotaka ^a   Fujieda, Megumi ^a   Ohfuji, Satoko ^a   Fukushima, Wakaba ^a   Kondo, Kyoko ^a   Maeda, Akiko ^a   Nakano, Takashi ^b   Kamiya, Hitoshi ^b   Hirota, Yoshio ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b MIE NATIONAL HOSPITAL   (Japan)

Author keywords

Influenza; Misclassification; Vaccine effectiveness

Indexed keywords

INACTIVATED VACCINE; INFLUENZA VACCINE;

ARTICLE; CHILD; DISEASE SEVERITY; DRUG EFFICACY; FEMALE; FLU LIKE SYNDROME; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; TREATMENT OUTCOME; VACCINATION;

CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; INFLUENZA VACCINES; INFLUENZA, HUMAN; JAPAN; MALE; ODDS RATIO; RISK FACTORS; TREATMENT OUTCOME; VACCINES, INACTIVATED;

EID: 70350574144     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2009.09.067     Document Type: Article

References (21)

1. Monto A.S., and Kioumehr F. The Tecumseh study of respiratory illness. IX. Occurrence of influenza in the community, 1966-1971. Am J Epidemiol 102 6 (1975) 553-563
2. Glezen W.P., and Couch R.B. Interpandemic influenza in the Houston area, 1974-1976. N Engl J Med 298 11 (1978) 587-592
3. Glezen W.P., Greenberg S.B., Atmar R.L., Piedra P.A., and Couch R.B. Impact of respiratory virus infections on persons with chronic underlying conditions. JAMA 283 4 (2000) 499-505
4. Center for Disease Control and Prevention. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 56 RR-6 (2007) 1-54
5. Poehling K.A., Edwards K.M., Weinberg G.A., Szilagyi P., Staat M.A., Iwane M.K., et al. The underrecognized burden of influenza in young children. N Engl J Med 355 1 (2006) 31-40
6. Fujieda M., Maeda A., Kondo K., Kaji M., and Hirota Y. Inactivated influenza vaccine effectiveness in children under 6 years of age during the 2002-2003 season. Vaccine 24 7 (2006) 957-963
7. Ritzwoller D.P., Bridges C.B., Shetterly S., Yamasaki K., Kolczak M., and France E.K. Effectiveness of the 2003-2004 influenza vaccine among children 6 months to 8 years of age, with 1 vs 2 doses. Pediatrics 116 1 (2005) 153-159
8. Allison M.A., Daley M.F., Crane L.A., Barrow J., Beaty B.L., Allred N., et al. Influenza vaccine effectiveness in healthy 6- to 21-month-old children during the 2003-2004 season. J Pediatr 149 6 (2006) 755-762
9. Neuzil K.M., Dupont W.D., Wright P.F., and Edwards K.M. Efficacy of inactivated and cold-adapted vaccines against influenza A infection, 1985 to 1990: the pediatric experience. Pediatr Infect Dis J 20 8 (2001) 733-740
10. Shuler C.M., Iwamoto M., Bridges C.B., Marin M., Neeman R., Gargiullo P., et al. Vaccine effectiveness against medically attended, laboratory-confirmed influenza among children aged 6 to 59 months, 2003-2004. Pediatrics 119 3 (2007) 587-595
11. Hurwitz E.S., Haber M., Chang A., Shope T., Teo S.T., Giesick J.S., et al. Studies of the 1996-1997 inactivated influenza vaccine among children attending day care: immunologic response, protection against infection, and clinical effectiveness. J Infect Dis 182 4 (2000) 1218-1221
12. Hoberman A., Greenberg D.P., Paradise J.L., Rockette H.E., Lave J.R., Kearney D.H., et al. Effectiveness of inactivated influenza vaccine in preventing acute otitis media in young children. A randomized controlled trial. JANA 290 12 (2003) 1608-1616
13. Eisenberg K.W., Szilagyi P.G., Fairbrother G., Griffin M.R., Staat M., Shone L.P., et al. Vaccine effectiveness against laboratory-confirmed influenza in children 6 to 59 months of age during the 2003-2004 and 2004-2005 influenza seasons. Pediatrics 122 5 (2008) 911-919
14. Szilagyi P.G., Fairbrother G., Griffin M.R., Hornung R.W., Donauer S., Morrow A., et al. Influenza vaccine effectiveness among children 6 to 59 months of age during 2 influenza seasons: a case-cohort study. Arch Pediatr Adolesc Med 162 10 (2008) 943-951
15. Hirota Y., Takeshita S., Ide S., Kataoka K., Ohkubo A., Fukuyoshi S., et al. Various factors associated with the manifestation of influenza-like illness. Int J Epidemiol 21 3 (1992) 574-582
16. Infectious Agents Surveillance Report. National Institute of Infectious Diseases and Tuberculosis and Infectious Diseases Control Division, Ministry of Health, Labour and Welfare 2001;22(12):309-10 [in Japanese].
17. Ohfuji S., Fukushima W., Irie S., Fujieda M., Ito K., Ishibashi M., et al. Immunogenicity of trivalent inactivated influenza vaccine among children less than 4 years of age. In: Katz J.M. (Ed). Options for the Control of Influenza, VI (2007), International Medical Press, Toronto 377-379
18. Izurieta H.S., Thompson W.W., Kramarz P., Shay D.K., Davis R.L., DeStefano F., et al. Influenza and the rates of hospitalization for respiratory disease among infants and young children. N Engl J Med 342 4 (2000) 232-239
19. Thompson W.W., Shay D.K., Weintraub E., Brammer L., Cox N., Anderson L.J., et al. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA 289 2 (2003) 179-186
20. Ozasa K. The effect of misclassification on evaluating the effectiveness of influenza vaccines. Vaccine 26 50 (2008) 6462-6465
21. Negri E., Colombo C., Giordano L., Groth N., Apolone G., and Vecchia C.L. Influenza vaccine in healthy children: a meta-analysis. Vaccine 23 (2005) 2851-2861